Aldeyra Therapeutics
Develops RASP modulators and ophthalmology candidates for immune-mediated diseases.
$1.51
After-hours close+0.03 (+1.68%)
At close$1.49(−3.57%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.11 | — | — |
| Aug 2026 | −$0.09 | −$0.09 | −2.9% |
| May 2026 | −$0.13 | −$0.06 | +53.8% |
| Feb 2026 | −$0.14 | −$0.11 | +21.4% |
| Nov 2025 | −$0.17 | −$0.13 | +23.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Oct 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.11 | — | — | $2.5M | — | — |
| Aug 6, 2026 | −$0.09 | −$0.09 | −2.9% | $31.3M | — | — |
| May 7, 2026 | −$0.13 | −$0.06 | +53.8% | — | — | — |
| Feb 27, 2026 | −$0.14 | −$0.11 | +21.4% | $4.8M | — | — |
| Nov 5, 2025 | −$0.17 | −$0.13 | +23.5% | $24.3M | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 14, 2025 | ||||||
| Feb 28, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 2, 2024 | ||||||
| Mar 7, 2024 | ||||||
| Nov 3, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 9, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 5, 2022 | ||||||
| May 5, 2022 | ||||||
| Mar 17, 2022 | ||||||
| Oct 28, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Mar 11, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 12, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 9, 2019 | ||||||
| Mar 8, 2019 | ||||||
| Nov 14, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 15, 2018 | ||||||
| Mar 29, 2018 | ||||||
| Nov 9, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 15, 2017 | ||||||
| Mar 30, 2017 | ||||||
| Nov 14, 2016 | ||||||
| Aug 10, 2016 | ||||||
| May 9, 2016 | ||||||
| Mar 30, 2016 | ||||||
| Nov 12, 2015 | ||||||
| Aug 11, 2015 | ||||||